Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidotes01:17

Antidotes

1.4K
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
1.4K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

271
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
271
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.9K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

80
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
80

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From leaf to cellulose scaffold: Decellularization and multi-scale characterization of <i>Neolamarckia cadamba</i> leaf for biomedical applications.

Journal of biomaterials applications·2026
Same author

Pentraxin-3 as a diagnostic and prognostic biomarker in inflammatory lung diseases.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Cognitive Impairment among Patients with Chronic Skin Inflammatory Disorder: A Hidden Link.

Indian dermatology online journal·2026
Same author

Validation of 12-lead Smartphone-based spandan ultra 12L electrocardiogram durations and amplitudes analysis as compared to the standard 12-lead electrocardiogram.

Biomedical physics & engineering express·2026
Same author

Epigenetic regulation of PANoptosis: DNA methylation, histone modifications and non-coding RNAs.

EXCLI journal·2026
Same author

Psychological First Aid for People Affected by Skin Diseases.

Indian dermatology online journal·2026

Related Experiment Video

Updated: Apr 25, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.0K

Recent Developments in Anti-dotes Against Anthrax.

Neha Dhasmana1, Lalit K Singh, Asani Bhaduri

  • 1CSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi 110007, India. neha.dhasmana@igib.in.

Recent Patents on Anti-Infective Drug Discovery
|September 2, 2014
PubMed
Summary

New strategies are needed to combat Bacillus anthracis infections, as current vaccines and antibiotics have limitations. Research focuses on developing novel inhibitors targeting anthrax virulence factors and host interactions.

More Related Videos

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

7.9K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.5K

Related Experiment Videos

Last Updated: Apr 25, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.0K
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

7.9K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.5K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biochemistry

Background:

  • Bacillus anthracis causes anthrax in livestock and humans globally.
  • Current anthrax prevention relies on animal vaccination and limited human vaccination for specific populations.
  • Antibiotic treatments face challenges from resistance and delayed diagnosis due to non-specific early symptoms.

Purpose of the Study:

  • To review recent advancements in developing countermeasures against Bacillus anthracis.
  • To highlight strategies targeting bacterial virulence factors and host-pathogen interactions.

Main Methods:

  • Review of studies on inhibitors of B. anthracis virulence factors (capsule, protective antigen, lethal factor, edema factor).
  • Analysis of research on inhibitors of anthrax toxin receptors and host furin endoproteases.
  • Synthesis of recent progress in diverse anti-anthrax strategies.

Main Results:

  • Development of specific inhibitors against B. anthracis virulence factors.
  • Exploration of receptor decoys and host enzyme inhibitors for toxin neutralization.
  • Focus on novel antimicrobial agents and diverse countermeasures.

Conclusions:

  • There is a critical need for new antimicrobial agents against virulent B. anthracis.
  • Targeting virulence factors and host-specific pathways offers promising avenues for anthrax control.
  • Recent research shows progress in developing diverse countermeasures against anthrax infections.